BIO from the BAYOU: Build Your Biotech Network with Key Opinion Leaders and Investors

Are you struggling to find investors, funding, collaborators, and strategic connections in the ever-changing world of biotech? This show empowers bio…
May 30th, 2024 | 26:17

Episode 37: Implementing a Chief Strategy Officer Role in Academic Medicine with Key Opinion Leader James Zanewicz

The tables turn as frequent host James Zanewicz, JD, LLM, RTTP, steps into the guest seat to discuss his position as Chief Strategy Officer at the Tulane University School of Medicine and Tulane National Primate Research Center. James shares the comprehensive strategies he has put in place at Tulane, including: fostering continuous dialogues with biotech companies and investors, positioning scientists and clinicians as key opinion leaders, and collaborating closely with startups to offer them services and access to Tulane’s expansive network. Guest host Allyson Best, MBA, also contributes her unique insights, making this a must-listen episode of BIO from the BAYOU.
Enjoyed the episode? Support us by liking, sharing, and subscribing to BIO from the BAYOU. Your engagement helps us bring more exciting content your way and reach more listeners passionate about the biotech industry.
Links:
Connect with James Zanewicz, JD, LLM, RTTP.
Learn about Tulane Medicine Business Development (NOTE: watch the events section of the website for info on AI+Healthcare Design) — and the Tulane School of Medicine.
Check out Informuta, BioAesthetics, AxoSim, Obatala, The Equalize Program, The Bullpen, Cleveland NeuroDesign, and The Alliance for Artificial Intelligence in Healthcare.
Connect with Alexis Ducote, PhD, MS, and Eric Malamud.
Connect with Allyson Best, MBA, and learn about The University of Mississippi.
Check out BIO on the BAYOU and make plans to attend October 29 & 30, 2024.
Learn more about BIO from the BAYOU – the podcast, the upcoming event, and more!
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.